News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
836,728 Results
Type
Article (85960)
Company Profile (649)
Press Release (750119)
Section
Business (232157)
Career Advice (4124)
Deals (39703)
Drug Delivery (125)
Drug Development (90763)
Employer Resources (198)
FDA (17968)
Job Trends (17309)
News (395423)
Policy (39637)
Tag
2024 BioCapital Digital (20)
2024 BioForest Digital (16)
2024 BioForest Standard (1)
2024 BioMidwest Digital (14)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (19)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (20)
2024 Biotech Beach Digital (15)
2024 Biotech Beach Standard (9)
2024 Genetown Digital (10)
2024 Genetown Standard (12)
2024 Lone Star Bio Digital (17)
2024 Pharm Country Digital (13)
2024 Pharm Country Standard (7)
2025 BioForest Digital (7)
2025 Lone Star Bio Digital (8)
2026 BioCapital Elite (1)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (2)
2026 Biotech Bay Elite (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (2)
2026 Genetown Elite (3)
2026 Pharm Country Elite (1)
2026 Pharm Country Premier (1)
2026 Pharm Country Standard (1)
Academia (2984)
Academic (1)
Accelerated approval (3)
Adcomms (25)
Allergies (75)
Alliances (56603)
ALS (72)
Alzheimer's disease (1438)
Antibody-drug conjugate (ADC) (126)
Approvals (17962)
Artificial intelligence (203)
Autoimmune disease (18)
Automation (10)
Bankruptcy (401)
Best Places to Work (12511)
BIOSECURE Act (21)
Biosimilars (114)
Biotechnology (447)
Bladder cancer (57)
Brain cancer (25)
Breast cancer (204)
Cancer (1775)
Cardiovascular disease (124)
Career advice (3527)
Career pathing (33)
CAR-T (149)
Cell therapy (418)
Cervical cancer (16)
Clinical research (72536)
Collaboration (712)
Compensation (376)
Complete response letters (27)
COVID-19 (2822)
CRISPR (39)
C-suite (188)
Cystic fibrosis (97)
Data (1623)
Decentralized trials (2)
Denatured (43)
Depression (34)
Diabetes (170)
Diagnostics (6731)
Digital health (8)
Diversity (9)
Diversity, equity & inclusion (48)
Drug discovery (106)
Drug pricing (91)
Drug shortages (17)
Duchenne muscular dystrophy (74)
Earnings (95040)
Editorial (33)
Employer branding (25)
Employer resources (167)
Events (127881)
Executive appointments (534)
FDA (18810)
Featured Employer (64)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (589)
Gene editing (91)
Generative AI (21)
Gene therapy (289)
GLP-1 (714)
Government (5072)
Grass and pollen (3)
Guidances (33)
Healthcare (20736)
Huntington's disease (24)
IgA nephropathy (23)
Immunology and inflammation (113)
Indications (22)
Infectious disease (2925)
Inflammatory bowel disease (145)
Inflation Reduction Act (11)
Influenza (39)
Intellectual property (77)
Interviews (812)
IPO (17674)
IRA (38)
Job creations (5183)
Job search strategy (2861)
Kidney cancer (10)
Labor market (37)
Layoffs (522)
Leadership (19)
Legal (10048)
Liver cancer (69)
Lung cancer (264)
Lymphoma (114)
Machine learning (2)
Management (65)
Manufacturing (253)
MASH (61)
Medical device (14282)
Medtech (14287)
Mergers & acquisitions (22233)
Metabolic disorders (552)
Multiple sclerosis (66)
NASH (22)
Neurodegenerative disease (87)
Neuropsychiatric disorders (23)
Neuroscience (1875)
NextGen: Class of 2025 (7665)
Non-profit (5054)
Northern California (2101)
Now hiring (38)
Obesity (300)
Opinion (267)
Ovarian cancer (67)
Pain (60)
Pancreatic cancer (56)
Parkinson's disease (117)
Partnered (16)
Patents (171)
Patient recruitment (81)
Peanut (48)
People (64688)
Pharmaceutical (131)
Pharmacy benefit managers (13)
Phase I (22401)
Phase II (31537)
Phase III (23717)
Pipeline (855)
Podcasts (121)
Policy (108)
Postmarket research (3542)
Preclinical (10066)
Press Release (72)
Prostate cancer (75)
Psychedelics (34)
Radiopharmaceuticals (248)
Rare diseases (333)
Real estate (7378)
Recruiting (75)
Regulatory (26300)
Reports (55)
Research institute (2643)
Resumes & cover letters (649)
Rett syndrome (1)
RNA editing (2)
RSV (30)
Schizophrenia (63)
Series A (117)
Series B (67)
Service/supplier (25)
Sickle cell disease (43)
Southern California (1801)
Special edition (18)
Spinal muscular atrophy (164)
Sponsored (33)
Startups (4281)
State (2)
Stomach cancer (11)
Supply chain (44)
The Weekly (75)
United States (18244)
Vaccines (703)
Venture capitalists (36)
Webinars (13)
Weight loss (221)
Women's health (35)
Worklife (18)
Date
Today (20)
Last 7 days (496)
Last 30 days (2178)
Last 365 days (30359)
2025 (6377)
2024 (34029)
2023 (42568)
2022 (53928)
2021 (58724)
2020 (57666)
2019 (51338)
2018 (39124)
2017 (37191)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36268)
2012 (38416)
2011 (38383)
2010 (39616)
Location
Africa (1264)
Alabama (50)
Alaska (6)
Arizona (238)
Arkansas (8)
Asia (49710)
Australia (8777)
California (4787)
Canada (1470)
China (444)
Colorado (154)
Connecticut (200)
Delaware (112)
Europe (113720)
Florida (589)
Georgia (134)
Hawaii (1)
Idaho (64)
Illinois (422)
India (23)
Indiana (255)
Iowa (9)
Japan (117)
Kansas (107)
Kentucky (16)
Louisiana (7)
Maine (58)
Maryland (792)
Massachusetts (3802)
Michigan (176)
Minnesota (299)
Mississippi (1)
Missouri (50)
Montana (24)
Nebraska (26)
Nevada (50)
New Hampshire (50)
New Jersey (1380)
New Mexico (27)
New York (1360)
North Carolina (955)
North Dakota (7)
Northern California (2101)
Ohio (155)
Oklahoma (13)
Oregon (44)
Pennsylvania (1025)
Puerto Rico (9)
Rhode Island (21)
South America (1647)
South Carolina (4)
South Dakota (1)
Southern California (1801)
Tennessee (29)
Texas (634)
Utah (107)
Virginia (90)
Washington D.C. (36)
Washington State (476)
West Virginia (1)
Wisconsin (35)
836,728 Results for "aditum bio".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Aditum Bio and Leads Biolabs Announce the Formation of Oblenio Bio to Develop a Tri-Specific T-Cell Engager for Autoimmune Disorders
November 7, 2024
·
3 min read
Biotech Bay
Aditum Bio Announces Formation of Celexor Bio, Focused on Cell Depletion of Pathologic Cells in Autoimmune and Inflammatory Disorders
Aditum Bio, the biotech investment firm cofounded in 2019 by former Novartis CEO Joe Jimenez and former President of the Novartis Institutes for BioMedical Research (NIBR) Dr. Mark Fishman, today announced the formation of Celexor Bio, a portfolio company created for the development of novel therapies for inflammatory disorders.
September 21, 2023
·
3 min read
Biotech Beach
Aditum Bio Announces Formation of Vitalli Bio, Focused on Immunological Disorders
Aditum Bio, the biotech investment firm cofounded in 2019 by former Novartis CEO Joe Jimenez and former President of the Novartis Institutes for BioMedical Research Dr. Mark Fishman, announced the formation of Vitalli Bio, a portfolio company created for the development of novel therapies for immunological disorders.
April 27, 2023
·
3 min read
Immunology and inflammation
Hillstar Bio Nets $67M Series A to Advance Autoimmune and Arthritis Pipeline
Led by alums from Takeda and Boston Pharmaceuticals, Hillstar Bio is working on treatments that remove harmful immune cells to relieve disease.
March 25, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
Tempero Bio Secures $70 Million Series B Financing to Advance TMP-301 into Phase 2 Trials for Substance Use Disorders
March 25, 2025
·
3 min read
Layoffs
Passage Bio Cutting 55% of Staff to Help Extend Cash Runway
Passage Bio’s workforce reduction could affect about 32 people, leaving the company with 26 employees as it continues evaluating a treatment for frontotemporal dementia with granulin mutations.
January 13, 2025
·
1 min read
·
Angela Gabriel
Press Releases
Nxera Pharma’s Partner Tempero Bio Initiates Phase 2 Trial with TMP-301 for Alcohol Use Disorder
March 25, 2025
·
4 min read
Business
Inmagene announces formation of Celexor Bio based on its anti-ILT7 mAb with enhanced pDC depletion function
Inmagene Biopharmaceuticals today announced its partnership with Aditum Bio to create Celexor Bio (Celexor), a new biotech company focused on cell depletion of pathologic cells in autoimmune and inflammatory disorders.
September 21, 2023
·
3 min read
I&I
Sanofi Commits up to $1.9B for Dren Bio’s Bispecific Antibody for Autoimmune Disease
The deal is the latest in a series of Sanofi investments in its immunology portfolio. According to Sanfoi, DR-0201 can achieve deep B cell depletion, giving it the potential to reset the immune system.
March 20, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Syneron Bio Announces Strategic Collaboration with AstraZeneca
March 21, 2025
·
1 min read
1 of 83,673
Next
